Department of Pharmacology, Egyptian Drug Authority, EDA, Giza, Egypt.
Department of Pharmacology and Toxicology, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt.
Biochem Pharmacol. 2020 Oct;180:114140. doi: 10.1016/j.bcp.2020.114140. Epub 2020 Jul 8.
Depression is a common mental illness that possesses a noteworthy effect on patients' lives. Many theories are recently studied for their plausible involvement in depression pathogenesis, especially oxidative stress and inflammation. Morin (2',3,4',5,7-pentahydroxyflavone), a natural flavonoid, is characterized by its potent anti-inflammatory, and anti-oxidant activities. Accordingly, the aim of the current study was to investigate its potential protective anti-depressant effect in the model of chronic unpredictable mild stress (CUMS) in experimental rats. Moreover, the conceivable neuro-protective mechanisms, especially those related to the inflammasome pathway, were explored. Several, mild, unpredictable stressors were applied for 4 weeks concomitantly with the oral administration of morin (15 and 30 mg/Kg). Morin hydrate supplementations exhibited a significant improvement in the scores of the forced swimming and sucrose preference tests. In addition, it prompted a marked elevation in the ambulation, rearing as well as grooming scores of the open field test. The morin-treated groups showed a great improvement in the biochemical parameters in both the cortex and hippocampus, where it significantly elevated the serotonin, epinephrine, and norepinephrine levels. Also, it significantly increased reduced glutathione levels and decreased malondialdehyde levels. Regarding the inflammasome pathway, morin significantly decreased the tissue levels of tumor necrosis factor-alpha, toll-like receptor-4, interleukin-1beta, NOD-like receptor pyrin domain-containing protein-3, and caspase-1 levels. Morin also significantly decreased the level of the key apoptotic marker, caspase-3. In conclusion, these findings propose that morin might show a promising anti-depressant effect.
抑郁症是一种常见的精神疾病,对患者的生活有显著影响。最近,许多理论被研究其可能参与抑郁症发病机制,特别是氧化应激和炎症。莫林(2',3,4',5,7-五羟基黄酮),一种天然类黄酮,以其强大的抗炎和抗氧化活性为特征。因此,本研究的目的是在实验大鼠慢性不可预测轻度应激(CUMS)模型中研究其潜在的保护抗抑郁作用。此外,还探讨了可能的神经保护机制,特别是与炎症小体途径相关的机制。在 4 周的时间内,同时给予莫林(15 和 30mg/kg)口服,应用了几种轻度、不可预测的应激源。莫林水合物补充剂在强迫游泳和蔗糖偏好测试中的评分有显著改善。此外,它明显提高了旷场试验中的运动、后肢站立和梳理评分。莫林治疗组在皮质和海马体的生化参数方面均有显著改善,其中显著提高了 5-羟色胺、肾上腺素和去甲肾上腺素水平。同时,它还显著增加了还原型谷胱甘肽水平,降低了丙二醛水平。关于炎症小体途径,莫林显著降低了肿瘤坏死因子-α、Toll 样受体-4、白细胞介素-1β、NOD 样受体吡喃结构域包含蛋白-3 和半胱天冬酶-1 的组织水平。莫林还显著降低了关键凋亡标志物半胱天冬酶-3 的水平。总之,这些发现表明莫林可能表现出有前途的抗抑郁作用。